Thu, February 24, 2022
Wed, February 23, 2022
Tue, February 22, 2022
Sun, February 20, 2022
Fri, February 18, 2022
Thu, February 17, 2022
Wed, February 16, 2022

Larry Biegelsen Maintained (ABT) at Buy and Held Target at $155 on, Feb 22nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-155-on-feb-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy and Held Target at $155 on, Feb 22nd, 2022.

Larry has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Larry's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Larry


  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $143 on, Thursday, January 27th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, December 15th, 2021
  • Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $146 on, Friday, December 10th, 2021
  • James Mainwaring of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $144 on, Wednesday, October 27th, 2021

Publication Contributing Sources